Replies to post #137363 on Biotech Values

[genisi]

I don't follow BCRX that closely and haven't looked at their HAE candidate. Perhaps a potential partner for gout will come after the 52 weeks data but like you said it's a crowded place.

[ghmm]

Gout, HAE, HCV. Is there some common element that ties these indications or something with their technology that enables them to pursue such different indications?

EDIT:

I guess I should have went to their website I see their mission is to block enzymes. But I also see they have oncology and flu programs. Seem a bit too diverse for such a small company.

I haven't looked at them but thought of investing in a company or two for Gout (aside from ALTU). I still think its a disease in need of a better treatment.